Product development

Enzymatica focuses on product development based on the tested and patented barrier technology used in the cold product ColdZyme. Strengthening the clinical documentation for ColdZyme is a key part of Enzymatica’s R&D activities.

Over the next few years the company aims to expand the range of enzyme-based products for colds. In the longer term, the intention is to develop products for other indications.